Dr. Albert Begas, MD

Dr. Begas practices at Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida.

Dr. Begas' NPI, 1245288315, was assigned on May 4, 2006. Dr. Begas graduated from University of Miami, Miller School of Medicine in 1982. Dr. Begas holds Florida license 50627.

Dr. Begas' primary practice is Boca Raton Regional Hospital, at 800 Meadows Rd, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 955-4200.

Dr. Begas' primary practice is Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida. The medical group on file is Eugene M. & Christine E. Lynn Cancer Institute (Lynn Cancer Institute). Dmand AI also links Dr. Begas to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Begas practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Begas' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Begas is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Begas' licenses on file in 2 states: Florida and New York.

Dmand AI lists breast cancer, chronic anemia, lung cancer and lymphedema among the conditions Dr. Begas treats.

CMS data shows 1,527 Medicare services from Dr. Begas across 5 procedure codes in 2024, for 303 Medicare patients. Medicare paid $71,983 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 303 Medicare patients who saw Dr. Begas in 2024. The largest group is 75 to 84, with 141 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Begas' median patient age at 75, with 87% women.

In 2024, Dr. Begas wrote 375 Medicare Part D claims for 111 patients. 78% of them were for generic drugs. CMS names the drug for 210 of them, across 6 drugs with 11 or more claims each, at $555,754 in total drug cost. In 2023, CMS named 276 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Begas for performance year 2024, reported individually. Dr. Begas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 510 general payments to Dr. Begas from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,265.

Dmand AI lists 5 awards for Dr. Begas, most recently Gulfstream FL-Palm Beach in 2014.

Dr. Begas graduated from University of Miami, Miller School of Medicine in 1982. Dr. Begas is a member of ASCO.

Dr. Begas is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.